Search results
CDSCO. Central Drugs Standard Control Organisation. Directorate General Of Health Services. Ministry of Health & Family Welfare, Government of India. SUGAM - An e-Governance solution for CDSCO.
List of Approved New Drugs. entries per page. Showing 1 to 10 of 37 entries. he Central Drugs Standard Control Organisation (CDSCO)under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India.
List of FDC & New Drugs Approved For Marketing in India. List of FDC & Subsequent New Drugs Approved in India. entries per page. Showing 1 to 10 of 43 entries.
2. Plazomicin injection 500mg/10ml (50mg/ml) Indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible microorganism(s) Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and. Enterobacter cloacae.
CDSCO. Central Drugs Standard Control Organisation. Directorate General Of Health Services. Ministry of Health & Family Welfare, Government of India. SUGAM - An e-Governance solution for CDSCO.
New drugs approved by CDSCO is published under drugs@ CDSCO section. Firms can request to test vaccine samples at CDL Kasauli and receive batch release certificate online. Firms can add their License details issued by State FDA's on SUGAM.
Central Drugs Standard Control Organization facilitates information about Approved Drugs by CDSCO
Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of New Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity ...
Veterinary Drugs & Vaccines Approved by CDSCO from January 2020 to 2024. List of Veterinary Drugs. List of Veterinary Vaccine and Drugs Approved by CDSCO from 2010 to 2019.
Sep 30, 2023 · National, 30 September 2023: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company today announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL & 100 mg/mL presentations in single-dose vials administered ...
